These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27454352)

  • 1. Detection of 2-hydroxyglutarate in brain tumors by triple-refocusing MR spectroscopy at 3T in vivo.
    An Z; Ganji SK; Tiwari V; Pinho MC; Patel T; Barnett S; Pan E; Mickey BE; Maher EA; Choi C
    Magn Reson Med; 2017 Jul; 78(1):40-48. PubMed ID: 27454352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo detection of 2-hydroxyglutarate in brain tumors by optimized point-resolved spectroscopy (PRESS) at 7T.
    Ganji SK; An Z; Tiwari V; McNeil S; Pinho MC; Pan E; Mickey BE; Maher EA; Choi C
    Magn Reson Med; 2017 Mar; 77(3):936-944. PubMed ID: 26991680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echo-planar spectroscopic imaging with dual-readout alternated gradients (DRAG-EPSI) at 7 T: Application for 2-hydroxyglutarate imaging in glioma patients.
    An Z; Tiwari V; Ganji SK; Baxter J; Levy M; Pinho MC; Pan E; Maher EA; Patel TR; Mickey BE; Choi C
    Magn Reson Med; 2018 Apr; 79(4):1851-1861. PubMed ID: 28833542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction of the GABA 2.29 ppm resonance using triple refocusing at 3 T in vivo.
    Tiwari V; An Z; Wang Y; Choi C
    Magn Reson Med; 2018 Oct; 80(4):1307-1319. PubMed ID: 29446149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D high-resolution imaging of 2-hydroxyglutarate in glioma patients using DRAG-EPSI at 3T in vivo.
    An Z; Tiwari V; Baxter J; Levy M; Hatanpaa KJ; Pan E; Maher EA; Patel TR; Mickey BE; Choi C
    Magn Reson Med; 2019 Feb; 81(2):795-802. PubMed ID: 30277274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo MRS measurement of 2-hydroxyglutarate in patient-derived IDH-mutant xenograft mouse models versus glioma patients.
    Tiwari V; Mashimo T; An Z; Vemireddy V; Piccirillo S; Askari P; Hulsey KM; Zhang S; de Graaf RA; Patel TR; Pan E; Mickey BE; Maher EA; Bachoo RM; Choi C
    Magn Reson Med; 2020 Sep; 84(3):1152-1160. PubMed ID: 32003035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the Utility of Short Echo Time (TE) Single Voxel 1H-MRS in Non-Invasive Detection of 2-Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModel.
    Heo H; Kim S; Lee HH; Cho HR; Xu WJ; Lee SH; Park CK; Park S; Choi SH; Kim H
    PLoS One; 2016; 11(1):e0147794. PubMed ID: 26820720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of 1H magnetic resonance spectroscopy for quantification of 2-hydroxyglutarate using linear combination and J-difference editing at 9.4T.
    Neuberger U; Kickingereder P; Helluy X; Fischer M; Bendszus M; Heiland S
    Z Med Phys; 2017 Dec; 27(4):300-309. PubMed ID: 28506858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo 2-hydroxyglutarate-proton magnetic resonance spectroscopy (3 T, PRESS technique) in treatment-naïve suspect lower-grade gliomas: feasibility and accuracy in a clinical setting.
    Cuccarini V; Antelmi L; Pollo B; Paterra R; Calatozzolo C; Nigri A; DiMeco F; Eoli M; Finocchiaro G; Brenna G; Tramacere I; Bruzzone MG; Anghileri E
    Neurol Sci; 2020 Feb; 41(2):347-355. PubMed ID: 31650436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma.
    Choi C; Raisanen JM; Ganji SK; Zhang S; McNeil SS; An Z; Madan A; Hatanpaa KJ; Vemireddy V; Sheppard CA; Oliver D; Hulsey KM; Tiwari V; Mashimo T; Battiste J; Barnett S; Madden CJ; Patel TR; Pan E; Malloy CR; Mickey BE; Bachoo RM; Maher EA
    J Clin Oncol; 2016 Nov; 34(33):4030-4039. PubMed ID: 28248126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma.
    Nagashima H; Tanaka K; Sasayama T; Irino Y; Sato N; Takeuchi Y; Kyotani K; Mukasa A; Mizukawa K; Sakata J; Yamamoto Y; Hosoda K; Itoh T; Sasaki R; Kohmura E
    Neuro Oncol; 2016 Nov; 18(11):1559-1568. PubMed ID: 27154922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of glycine in healthy and tumorous brain by triple-refocusing MRS at 3 T in vivo.
    Tiwari V; An Z; Ganji SK; Baxter J; Patel TR; Pan E; Mickey BE; Maher EA; Pinho MC; Choi C
    NMR Biomed; 2017 Sep; 30(9):. PubMed ID: 28548710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of edited 2HG MR spectroscopy of central glioma in the clinical environment.
    Juskanič D; Mištinová JP; Hollý S; Sekerešová M; Koleják K; Pátrovič L
    MAGMA; 2022 Feb; 35(1):45-52. PubMed ID: 34985589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved resolution of glutamate, glutamine and γ-aminobutyric acid with optimized point-resolved spectroscopy sequence timings for their simultaneous quantification at 9.4 T.
    Dobberthien BJ; Tessier AG; Yahya A
    NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29105187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectral fitting strategy to overcome the overlap between 2-hydroxyglutarate and lipid resonances at 2.25 ppm.
    Askari P; Dimitrov IE; Ganji SK; Tiwari V; Levy M; Patel TR; Pan E; Mickey BE; Malloy CR; Maher EA; Choi C
    Magn Reson Med; 2021 Oct; 86(4):1818-1828. PubMed ID: 33977579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.
    de la Fuente MI; Young RJ; Rubel J; Rosenblum M; Tisnado J; Briggs S; Arevalo-Perez J; Cross JR; Campos C; Straley K; Zhu D; Dong C; Thomas A; Omuro AA; Nolan CP; Pentsova E; Kaley TJ; Oh JH; Noeske R; Maher E; Choi C; Gutin PH; Holodny AI; Yen K; DeAngelis LM; Mellinghoff IK; Thakur SB
    Neuro Oncol; 2016 Feb; 18(2):283-90. PubMed ID: 26691210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of 2-hydroxyglutarate quantification by short-echo proton-MRS at 3 T: a phantom study.
    Bertolino N; Marchionni C; Ghielmetti F; Burns B; Finocchiaro G; Anghileri E; Bruzzone MG; Minati L
    Phys Med; 2014 Sep; 30(6):702-7. PubMed ID: 24685182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of short- and long-TE ¹H MRS at 3 T for in vivo detection of 2-hydroxyglutarate in brain tumors.
    Choi C; Ganji S; Hulsey K; Madan A; Kovacs Z; Dimitrov I; Zhang S; Pichumani K; Mendelsohn D; Mickey B; Malloy C; Bachoo R; Deberardinis R; Maher E
    NMR Biomed; 2013 Oct; 26(10):1242-50. PubMed ID: 23592268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR spectroscopy for in vivo assessment of the oncometabolite 2-hydroxyglutarate and its effects on cellular metabolism in human brain gliomas at 9.4T.
    Bisdas S; Chadzynski GL; Braun C; Schittenhelm J; Skardelly M; Hagberg GE; Ethofer T; Pohmann R; Shajan G; Engelmann J; Tabatabai G; Ziemann U; Ernemann U; Scheffler K
    J Magn Reson Imaging; 2016 Oct; 44(4):823-33. PubMed ID: 26970248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Hydroxyglutarate magnetic resonance spectroscopy in adult brainstem glioma.
    Iwahashi H; Nagashima H; Tanaka K; Uno T; Hashiguchi M; Maeyama M; Somiya Y; Komatsu M; Hirose T; Itoh T; Sasaki R; Sasayama T
    J Neurosurg; 2023 Aug; 139(2):355-362. PubMed ID: 36708540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.